Global oncology drug spending is expected to hit $441B by 2029 despite patent expirations later in the decade. Read more here ...

ZoomRx polled 50 experienced oncologists and hemato-oncologists about 20 cancer drugmakers, asking the doctors to rank the ...

The partnership will include $105m upfront to Orionis, with the potential for further payments that could exceed $2bn.

The latest data from studies across Bayer’s oncology and women’s health portfolios will be presented at the upcoming 2025 ...

Thanks to exchange-traded funds (ETFs), investors don’t have to be tied to one specific stock. When it comes to biotech ETFs, ...

Visit the American Cancer Society’s Cancer Statistics Center for more key statistics. Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as editors ...